AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own CDW, you need to believe it can keep evolving from a transactional IT reseller into a solutions partner anchored in AI, cloud, and services. The recent layoffs tied to AI investments speak directly to the near term earnings risk around operating leverage and margin pressure. For now, the announcement looks more like a refinement of the cost base than a change to the core thesis, but it sharpens the focus on execution risk around expense control.
Against that backdrop, CDW’s decision in May 2026 to lift its share repurchase authorization by another US$1,000 million stands out. Together with regular dividends, it shows the company continuing to commit significant capital to shareholders even as it reshapes its cost structure for AI centric growth. How effectively CDW balances these buybacks with the need to absorb restructuring costs will matter for how investors assess its earnings trajectory over the next few years.
Yet beneath the AI opportunity, investors should still be aware of the risk that rising operating costs could collide with softer gross margins if...
Read the full narrative on CDW (it's free!)
CDW's narrative projects $25.4 billion revenue and $1.4 billion earnings by 2029. This requires 3.6% yearly revenue growth and about a $0.3 billion earnings increase from $1.1 billion today.
Uncover how CDW's forecasts yield a $152.56 fair value, a 14% upside to its current price.
Some of the lowest ranked analysts see a harsher path, with revenue growing only about 1.6% a year and earnings near US$1.4 billion by 2029, so you should weigh whether the new AI driven cost cuts really offset those margin worries or if their more cautious view still makes sense for you.
Explore 5 other fair value estimates on CDW - why the stock might be worth as much as 80% more than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com